Paroxysmal nocturnal hemoglobinuria: correction of abnormal phenotype by somatic cell hybridization

Somat Cell Mol Genet. 1993 Mar;19(2):123-9. doi: 10.1007/BF01233528.

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired blood disorder thought to result from a somatic mutation in a hemopoietic stem cell. PNH may evolve to aplastic anemia or to acute leukemia. PNH cells are deficient in proteins attached to the cell membrane via a glycosylphosphatidylinositol structure, called the GPI anchor, and the primary lesion in PNH is thought to be a defect in the biosynthesis of the GPI anchor. We have recently established permanent lymphoblastoid cell lines that have the PNH phenotype and we report now the isolation of human-human somatic cell hybrid clones obtained by fusing them with normal lymphoblastoid cells. In all of 21 hybrid clones, obtained from five different patients, the expression of three different GPI-linked proteins on the hybrid cells was normal. These findings indicate that the PNH mutant gene is recessive with respect to the normal allele and that a recessive mutation can cause a clonal preneoplastic disorder.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Southern
  • Carbohydrate Sequence
  • Cell Line, Transformed
  • Flow Cytometry
  • Genes, Recessive
  • Hemoglobinuria, Paroxysmal / genetics*
  • Humans
  • Hybrid Cells*
  • Molecular Sequence Data
  • Mutation
  • Phenotype